Chapter 36: No Rescue Clause
Four days after the restricted hearing, Julian brought his one-page commercial-conflict notice to the external administrator's escrow desk. He had not asked what happened behind the sealed door.
No evidence files entered the room. A conflict matrix, two recusal certificates, and a sealed-bid receipt sat between us.
I had requested all three.
Celeste had found one legitimate objection inside her attempt to redirect the review. Mercer Nova employed me and wanted limited development rights. Julian had no vote and no access to restricted evidence, but a potential benefit remained. I could defend that distinction for weeks.
Or I could remove it.
"Mercer Nova will have no contact with the licensing panel about the merits," I said. "Its offer will remain sealed with the independent custodian. No amendments after the formal window closes. No access to competing terms, deliberations, or nonpublic findings."
The administrator marked each condition on the matrix.
Julian read the last clause. "And no priority if Sterling's suspension is confirmed."
"Correct," Rhea said. "The trust may delay any award, reject every offer, or reopen the process. Mercer would carry its own preparation costs without assurance of a license."
Celeste leaned back. "A convenient performance. He signs a page, then receives the asset when you win."
"No transfer is authorized by this certificate," the administrator said. "No future award is guaranteed."
Nathan examined the escrow terms. He had not brought the invoice dispute into an open procedural room. I did not bring it out for him. The sealed evidence stayed sealed, and Julian never asked me to explain it.
"Mercer should withdraw its offer entirely," Nathan said.
"Sterling asked for commercial conflicts to be settled," Rhea replied. "The panel is separating the bidder from the decision. It is not eliminating a qualified bid because Sterling requested it."
The administrator turned to me. My certificate went further than Julian's. It prohibited me from participating in Mercer Nova's bid strategy while I remained the trust's scientific observer. I could advise on license conditions common to every applicant. I could not tell Mercer what Sterling had submitted or help it adjust a price.
That restriction would last through the review.
Julian could have assigned another executive to preserve his own access to the competition. Instead, he signed the company certificate and handed it across the desk.
"Deposit the bid security," he said.
His finance officer transferred the required amount into escrow. The receipt changed from PENDING to IRREVOCABLE THROUGH REVIEW CLOSE. Money Mercer Nova could have used elsewhere would remain unavailable while the panel decided whether Sterling had cured its breaches.
Celeste looked at me. "You are willing to freeze his capital to punish your family."
"I am willing to keep his capital from purchasing my answer."
Julian did not defend me. He signed the acknowledgment that barred him from receiving more than procedural notices. Then he asked the question he had waited to ask until the decision was mine.
"Do you want any other separation?"
"No private updates from me. If the public finding is all you are entitled to, it is all you get."
"Understood."
The administrator sealed his certificate with the bid record. Celeste's conflict objection remained preserved, but the matrix now showed no Mercer representative in the decision chain, no route from me to its commercial team, and no ability to improve its position from restricted information.
I had not proved anything about Nathan's invoice.
I had made it impossible for Sterling to use Mercer's interest as an answer to it.
The formal bidding window stayed open for four more business days so every qualified applicant faced the same deadline. Julian left with a receipt and no information about what his company might be competing against.
At four on the final day, the escrow registry posted one new entry.
Sterling Biotech had submitted a sealed commercial-price envelope.